Hillhouse Investment's Health Care Portfolio

Musely is a prescription wellness company with a focus on accessible and effective telemedicine.

Axoft is a revolutionary seamless interface between brain and machine.

Angitia Biopharmaceuticals develops biologic therapies for musculoskeletal diseases.

Third Arc Bio is a biotech company developing multifunctional antibodies for inflammatory and immunology diseases.

Cryofocus Biotech cryoablation device manufacturer.

Designing innovative technologies focused on accelerating global access to biotherapeutics.

MAXVAX aims to provide novel vaccine development and commercialization.

NextCure is a biopharmaceutical company focused on discovering and developing next generation immuno-oncology-based drugs.

GRIT Biotechnology develops tumor infiltration lymphocytes immunotherapy for solid tumors.

Arvinas advances therapies degrading disease-causing proteins for life-threatening diseases, from discovery to commercialization.

CStone Pharmaceuticals is a bio-pharmaceutical company develops new treatments in a range of therapeutic areas.

Immorna specializes in the production of RNA-based therapeutics.

Qitan Technology is a Developer of a genome sequencing technology.

Hopson Technology is a natural product synthesis technology developer.

Gossamer Bio is a biopharmaceutical company focused on the discovery and development of novel and differentiated therapeutic products.

Tianyu Healthcare is a tech-enabled platform providing door-to-door elderly care services.

Antiva Biosciences is a biopharmaceutical company developing therapeutics for the treatment of diseases caused by HPV infection.

Ruipeng Pet Hospital is a Shenzhen-based pet medical and beauty care hospital operator.

Thousand Oaks Biopharmaceuticals is a developer of biopharmaceutical technologies intended to produce protein and vaccine compounds.